Collins Stewart Initiates Coverage on Specialty Pharma Companies
Tweet Send to a Friend
Collins initiates coverage on Alcon (NYSE: ACL) with a Buy and $96 price target. Initiates ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


